Novel N,N-dialkyl cyanocinnamic acids as monocarboxylate transporter 1 and 4 inhibitors

von Jonnalagadda, Shirisha, Jonnalagadda, Sravan K., Ronayne, Conor T., Nelson, Grady L., Solano, Lucas N., Rumbley, Jon, Holy, Jon, Mereddy, Venkatram R., Drewes, Lester R.
Veröffentlicht in Oncotarget (2019)

Coumarin carboxylic acids as monocarboxylate transporter 1 inhibitors: In vitro and in vivo studies as potential anticancer agents

von Gurrapu, Shirisha, Jonnalagadda, Sravan K., Alam, Mohammad A., Ronayne, Conor T., Nelson, Grady L., Solano, Lucas N., Lueth, Erica A., Drewes, Lester R., Mereddy, Venkatram R.
Veröffentlicht in Bioorg Med Chem Lett (2016)

Development of Novel Silyl Cyanocinnamic Acid Derivatives as Metabolic Plasticity Inhibitors for Cancer Treatment

von Nelson, Grady L., Ronayne, Conor T., Solano, Lucas N., Jonnalagadda, Sravan K., Jonnalagadda, Shirisha, Rumbley, Jon, Holy, Jon, Rose-Hellekant, Teresa, Drewes, Lester R., Mereddy, Venkatram R.
Veröffentlicht in Sci Rep (2019)

Synthesis, in vitro, and in vivo evaluation of novel N-phenylindazolyl diarylureas as potential anti-cancer agents

von Solano, Lucas N., Nelson, Grady L., Ronayne, Conor T., Jonnalagadda, Shirisha, Jonnalagadda, Sravan K., Kottke, Kaija, Chitren, Robert, Johnson, Joseph L., Pandey, Manoj K., Jonnalagadda, Subash C., Mereddy, Venkatram R.
Veröffentlicht in Sci Rep (2020)